Menu
You have to log in or sign up before you can proceed.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€96.54

€96.54

0.060%
0.06
0.060%
-

-

 
16.09.24 / Tradegate WKN: 753718 / Symbol: ZMH / Name: Zimmer Biomet / Stock / Healthcare Equipment & Supplies / Large Cap /

Zimmer Holdings Stock

There is nearly no change for the Zimmer Holdings stock today. Compared to yesterday it only changed by €0.060.

Pros and Cons of Zimmer Holdings in the next few years

Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Zimmer Holdings vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Zimmer Holdings 0.060% 1.259% -3.605% -15.204% -12.236% -22.302% -25.105%
Dexcom Inc. 1.240% -0.193% -8.387% -31.356% -44.587% -48.278% 78.712%
Dentsply Sirona Inc. 1.410% 5.673% 3.846% -27.968% -25.326% -53.966% -48.206%
Teleflex Inc. -2.730% 0.000% 2.804% 10.000% -0.901% -31.677% -24.927%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-02

When evaluating the financial health of Zimmer Biomet Holdings, Inc. (US symbol: ZMH), reflections on its financials reveal a complex yet compelling picture for private investors keen on the healthcare equipment and supplies domain. With a rich landscape involving innovative medical devices and exceptionally strategic operations, the analysis below navigates through the company's balance sheet, income statement, and cash flow statement.

A general impression of Zimmer Biomet’s financials indicates a company that possesses considerable assets and solid revenue generation capabilities, but it also faces certain liabilities and challenges that require careful consideration. The past few years have displayed volatility in earnings growth, a focus on research and development, and significant investments that underline the company's commitment to innovation.

Pros: ** 1. **Strong Total Assets: As of December 31, 2023, Zimmer Biomet reported total assets of approximately $21.5 billion. This indicates a sturdy foundation, affording the company the flexibility to pursue growth opportunities. 2. Robust Stockholder Equity: At $12.5 billion, the total stockholder equity represents a healthy equity cushion, offering reassurance to investors regarding the overall financial stability of the company. 3. Goodwill and Intangible Assets: The presence of significant intangible assets, including goodwill of about $8.8 billion, reflects strategic acquisitions that have the potential to contribute to long-term revenue streams. This demonstrates the company’s focus on retaining competitive advantages through their products and brand identity.

Comments

Prediction Buy
Perf. (%) 4.23%
Target price 115.500
Change
Ends at 19.08.25

Hey there! So, I've been digging into Zimmer Biomet, and I've gotta say, I'm pretty pumped about this stock. Sure, it's had a bit of a rough year, down 11%, but that's just created a juicy opportunity for us savvy investors. Think of it like finding a designer jacket on the clearance rack – it's still top-quality, just at a bargain price. What's got me excited? Well, Zimmer's killing it in the robotic surgery game. They've just inked a deal to distribute THINK Surgical's TMINI system for knee replacements. It's like they're adding a sports car to their already impressive fleet of surgical robots. And let's not forget their ROSA Shoulder system – they're literally giving surgeons a helping hand (or should I say, robotic arm?). Now, the market's been a bit distracted by all the macro noise – you know, interest rates, Fed chatter, that sort of thing. But if we zoom out and look at the big picture, Zimmer's in a sweet spot. The robotic surgery market is booming, expected to hit $7.87 billion by 2029. That's like finding a gold mine in your backyard! Sure, there are some headwinds like currency fluctuations, but Zimmer's innovation game is strong. They're not just sitting pretty – they're constantly pushing the envelope in orthopaedic solutions. So, what's the bottom line? I think Zimmer's primed for a comeback. The recent earnings were solid, even with some unusual expenses weighing things down. Once those clear up, we could see profits pop. It's like Zimmer's a coiled spring, ready to bounce back. Now, I'm not saying mortgage your house and go all-in, but at this price? It's looking pretty tempting to add some Zimmer to the portfolio. Just remember, I'm just a fellow investor sharing my thoughts – always do your own homework before making any moves!
Show more